Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Suga

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1991
[Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]K Torizuka, S K Ha-Kawa, K Ikekubo, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analoguesK Ohsumi, T Hatanaka, K Fujita, et al.
Anti-Cancer Drug Design|June 2, 2000
Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatinsK Ohsumi, T Hatanaka, R Nakagawa, et al.
Cardiology|January 1, 1995
Clinical significance of S-T segment elevation in lead aVR in anterior myocardial infarction. Assessment by thallium-201 exercise scintigraphyH Nakamori, T Iwasaka, T Shimada, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationshipsK Ohsumi, R Nakagawa, Y Fukuda, et al.
Clinical and Experimental Dermatology|August 12, 2006
A case of a Japanese neonate with congenital ichthyosiform erythroderma diagnosed as Netherton syndromeY Mizuno, Y Suga, K Haruna, et al.
The Journal of Cell Biology|October 19, 2000
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratodermaY Suga, M Jarnik, P S Attar, et al.
International Journal of Laboratory Hematology|February 14, 2018
Optimisation of antithrombin resistance assay as a practical clinical laboratory test: Development of prothrombin activator using factors Xa/Va and automation of assayS Tamura, Y Suga, M Tanamura, et al.
Experimental Dermatology|February 25, 2000
Hot spot mutations in keratin 2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of SiemensY Suga, M J Arin, G Scott, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseasesH Asakura, Y Ontachi, T Mizutani, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1991
[Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]K Torizuka, S K Ha-Kawa, K Ikekubo, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analoguesK Ohsumi, T Hatanaka, K Fujita, et al.
Anti-Cancer Drug Design|June 2, 2000
Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatinsK Ohsumi, T Hatanaka, R Nakagawa, et al.
Cardiology|January 1, 1995
Clinical significance of S-T segment elevation in lead aVR in anterior myocardial infarction. Assessment by thallium-201 exercise scintigraphyH Nakamori, T Iwasaka, T Shimada, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationshipsK Ohsumi, R Nakagawa, Y Fukuda, et al.
Clinical and Experimental Dermatology|August 12, 2006
A case of a Japanese neonate with congenital ichthyosiform erythroderma diagnosed as Netherton syndromeY Mizuno, Y Suga, K Haruna, et al.
The Journal of Cell Biology|October 19, 2000
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratodermaY Suga, M Jarnik, P S Attar, et al.
International Journal of Laboratory Hematology|February 14, 2018
Optimisation of antithrombin resistance assay as a practical clinical laboratory test: Development of prothrombin activator using factors Xa/Va and automation of assayS Tamura, Y Suga, M Tanamura, et al.
Experimental Dermatology|February 25, 2000
Hot spot mutations in keratin 2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of SiemensY Suga, M J Arin, G Scott, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseasesH Asakura, Y Ontachi, T Mizutani, et al.
Pageof 8